European Journal of Cardiovascular Medicine

Chronic Liver Disease (CLD) is a major cause of morbidity and mortality worldwide and constitutes a significant public health challenge, particularly in developing countries such as India. It encompasses a spectrum of progressive hepatic disorders characterized by persistent inflammation, fibrosis, architectural distortion, and eventual cirrhosis. Common etiologies include chronic viral hepatitis (hepatitis B and C), alcohol-related liver disease, non-alcoholic fatty liver disease (NAFLD), autoimmune hepatitis, and metabolic liver disorders. As liver damage progresses, patients develop complications such as portal hypertension, ascites, hepatic encephalopathy, variceal bleeding, and hepatocellular carcinoma, significantly affecting quality of life and survival.

The liver plays a pivotal role in maintaining hemostatic balance. It is responsible for the synthesis of most coagulation factors, anticoagulant proteins, fibrinolytic factors, and thrombopoietin, which regulates platelet production. Consequently, chronic liver disease is frequently associated with profound disturbances in the hemostatic system. These abnormalities include thrombocytopenia, platelet dysfunction, and decreased synthesis of clotting factors, vitamin K deficiency, enhanced fibrinolysis, and alterations in endothelial function. Such derangements predispose patients to spontaneous bleeding manifestations involving various organ systems.

Bleeding tendencies in chronic liver disease arise from multiple mechanisms. Thrombocytopenia is among the most common hematological abnormalities observed in cirrhotic patients and may result from hypersplenism secondary to portal hypertension, reduced thrombopoietin production by the diseased liver, bone marrow suppression, or immune-mediated platelet destruction. In addition, qualitative platelet dysfunction contributes significantly to impaired primary hemostasis. Reduced levels of coagulation factors synthesized by the liver further compromise the coagulation cascade, while increased fibrinolytic activity promotes premature clot dissolution. These combined factors render patients susceptible to spontaneous mucocutaneous and internal hemorrhages.

The eye is a highly vascular organ and often serves as a window to systemic disease. Ocular manifestations may reflect underlying hematological, vascular, metabolic, and systemic disorders. Various systemic conditions such as diabetes mellitus, hypertension, and leukemia, anemia, and coagulation disorders can produce characteristic ocular findings. Similarly, chronic liver disease can affect ocular tissues through alterations in coagulation, vascular integrity, and systemic hemodynamics. Although jaundice and scleral icterus are well-recognized ophthalmic signs of liver disease, hemorrhagic ocular manifestations remain relatively underexplored.

Among the ocular hemorrhagic manifestations associated with chronic liver disease, subconjunctival hemorrhage and retinal hemorrhage are of particular clinical importance. These lesions may occur spontaneously in the absence of trauma and can serve as indicators of underlying hemostatic dysfunction.

Subconjunctival hemorrhage (SCH) is characterized by the accumulation of blood beneath the bulbar conjunctiva due to rupture of small conjunctival vessels. Clinically, it appears as a sharply demarcated red patch over the sclera and is usually painless, self-limiting, and visually insignificant. While SCH is commonly associated with local trauma, Valsalva maneuvers, hypertension, and anticoagulant therapy, recurrent or spontaneous episodes may indicate systemic disorders including bleeding diatheses and hematological abnormalities. In patients with chronic liver disease, impaired coagulation and thrombocytopenia may predispose to spontaneous rupture of fragile conjunctival vessels. Despite being easily visible during routine examination, SCH is often overlooked because it rarely causes symptoms or visual impairment.

Retinal hemorrhage, on the other hand, carries greater clinical significance because of its potential impact on vision. Retinal hemorrhages result from leakage of blood from retinal capillaries, venules, or arterioles into various retinal layers. Depending on their location and extent, retinal hemorrhages may cause visual disturbances ranging from mild blurring to severe vision loss. In chronic liver disease, thrombocytopenia, coagulopathy, anemia, and vascular fragility may contribute to retinal vascular leakage and hemorrhage. Furthermore, portal hypertension and systemic circulatory alterations may exacerbate retinal vascular abnormalities. The presence of retinal hemorrhage may therefore indicate advanced systemic disease and severe hematological derangement.

Several studies have demonstrated associations between thrombocytopenia and retinal hemorrhages in patients with hematological disorders. Similar mechanisms may operate in chronic liver disease, where platelet counts frequently decline with disease progression. Prolonged prothrombin time and elevated International Normalized Ratio (INR), commonly used markers of impaired coagulation in liver disease, may also correlate with the occurrence of ocular hemorrhages. However, available evidence regarding the prevalence and determinants of ocular hemorrhages in CLD remains limited.

The severity of chronic liver disease is commonly assessed using prognostic scoring systems such as the Child–Pugh classification and the Model for End-Stage Liver Disease (MELD) score. As hepatic dysfunction worsens, the degree of coagulopathy and thrombocytopenia generally increases. It is therefore plausible that ocular hemorrhagic manifestations may occur more frequently in patients with advanced liver disease. Identification of such associations could provide clinicians with a simple, non-invasive marker of disease severity and bleeding risk.

Despite the growing burden of chronic liver disease in India, ophthalmic manifestations of hepatic disorders have received relatively little attention. Most available studies evaluating ocular hemorrhages in liver disease are retrospective, involve small sample sizes, or focus primarily on systemic bleeding complications rather than ocular findings. Prospective studies examining the prevalence of spontaneous subconjunctival and retinal hemorrhages and their relationship with hematological parameters are scarce, particularly in the Indian population.

Early detection of ocular hemorrhages may have important clinical implications. Recognition of subconjunctival or retinal hemorrhages during routine ophthalmic examination may prompt evaluation for underlying coagulation abnormalities and facilitate timely intervention. Furthermore, understanding the relationship between ocular hemorrhages and laboratory markers such as platelet count and INR may help identify patients at increased risk of systemic bleeding complications.

Given the paucity of prospective data and the potential clinical significance of these findings, the present study was undertaken to evaluate spontaneous subconjunctival and retinal hemorrhages in patients with chronic liver disease. The study aims to determine the prevalence of these ocular manifestations and to assess their association with platelet count, coagulation profile, and severity of liver disease. The findings may contribute to improved interdisciplinary collaboration between hepatologists and ophthalmologists and enhance understanding of the ocular consequences of chronic liver disease.

AIMS AND OBJECTIVES

Aim

To evaluate the occurrence and clinical significance of spontaneous subconjunctival hemorrhage and retinal hemorrhage in patients with chronic liver disease

Objectives

1. To determine the prevalence of spontaneous subconjunctival hemorrhage and retinal hemorrhage in patients with chronic liver disease.
2. To evaluate the association between ocular hemorrhagic manifestations and platelet count in patients with chronic liver disease.
3. To assess the correlation between ocular hemorrhages and coagulation status as measured by the International Normalized Ratio (INR).
4. To correlate the occurrence of spontaneous subconjunctival and retinal hemorrhages with the severity of chronic liver disease using the Child–Pugh classification.
5. To evaluate the clinical significance of spontaneous ocular hemorrhages as indicators of systemic coagulopathy and disease severity in patients with chronic liver disease.

REVIEW OF LITERATURE

1. Poordad F. (2007) – Thrombocytopenia in Chronic Liver Disease

Poordad conducted a comprehensive review examining the prevalence and clinical significance of thrombocytopenia in chronic liver disease. The author highlighted that thrombocytopenia is one of the most common hematological abnormalities in cirrhotic patients and occurs due to portal hypertension-induced splenic sequestration, decreased thrombopoietin production, and bone marrow suppression. The review emphasized that declining platelet counts often parallel worsening liver function and contribute significantly to bleeding complications. The study suggested that thrombocytopenia may serve as an indirect marker of disease severity and bleeding risk.

Relevance to Present Study: Since retinal and subconjunctival hemorrhages are bleeding manifestations, the relationship between platelet count and ocular hemorrhage warrants prospective evaluation.

2. Peck-Radosavljevic M. (2017) – Thrombocytopenia in Chronic Liver Disease

In this extensive review, thrombocytopenia was identified as a multifactorial complication occurring frequently in advanced chronic liver disease. The author demonstrated that severity of thrombocytopenia increases with progression of hepatic dysfunction. Reduced thrombopoietin synthesis and hypersplenism were identified as major contributors. The review also highlighted the impact of thrombocytopenia on spontaneous bleeding episodes and procedural outcomes.

Relevance to Present Study: Advanced liver disease may predispose patients to ocular hemorrhages through progressive platelet depletion and vascular fragility.

3. Scharf R.E. (2021) – Thrombocytopenia and Hemostatic Changes in Acute and Chronic Liver Disease

Scharf reviewed the complex alterations in hemostasis associated with liver disease. The study reported that up to 75% of patients with cirrhosis develop thrombocytopenia. Apart from platelet abnormalities, reductions in clotting factor synthesis, increased fibrinolysis, and endothelial dysfunction contribute to bleeding tendencies. The author emphasized that platelet count reduction often precedes clinical decompensation and can be a useful biomarker of disease progression.

Relevance to Present Study: Ocular hemorrhages may represent clinically visible manifestations of these hemostatic abnormalities.

4. Patel R. et al. (2024) – Ocular Manifestations of Liver Disease: An Important Diagnostic Aid

Patel and colleagues published a comprehensive review of ophthalmic manifestations associated with liver diseases. The authors reported that liver disorders may affect multiple ocular structures through metabolic, vascular, inflammatory, and hematological mechanisms. Retinal vascular abnormalities, retinopathies, xerophthalmia, and ocular hemorrhages were highlighted as important manifestations. The review emphasized that ophthalmic findings can provide valuable clues regarding systemic disease severity.

Relevance to Present Study: Supports the concept that ocular examination may reveal clinically important manifestations of chronic liver disease.

5. Tarlan and Kiratli (2013) – Subconjunctival Hemorrhage: Risk Factors and Potential Indicators

This review analyzed risk factors associated with spontaneous subconjunctival hemorrhage. The authors identified hypertension, diabetes mellitus, anticoagulant therapy, thrombocytopenia, and systemic bleeding disorders as major contributors. Recurrent spontaneous SCH was suggested as a potential indicator of underlying systemic disease requiring further investigation.

Relevance to Present Study: Chronic liver disease-associated coagulopathy and thrombocytopenia may similarly contribute to spontaneous SCH occurrence.

6. Joshi and Bandgar (2021) – Incidence of Non-Traumatic Subconjunctival Hemorrhage in an Indian Rural Population

This observational study evaluated non-traumatic subconjunctival hemorrhage in an Indian population. The authors reported that systemic disorders constituted a substantial proportion of underlying causes. Hematological abnormalities and coagulation disturbances were frequently associated with spontaneous hemorrhage. The study highlighted the importance of identifying systemic etiologies in apparently benign ocular presentations.

Relevance to Present Study: Supports the need to investigate systemic hematological parameters in patients presenting with spontaneous ocular hemorrhage.

7. Lim H.I. and Cuker A. (2022) – Thrombocytopenia and Liver Disease: Pathophysiology and Management

This review discussed mechanisms of thrombocytopenia in chronic liver disease and their clinical implications. The authors described decreased platelet production, increased destruction, and splenic sequestration as major causes. They emphasized that thrombocytopenia contributes substantially to spontaneous bleeding manifestations and is frequently associated with advanced cirrhosis.

Relevance to Present Study: Provides pathophysiological support for investigating platelet count as a predictor of retinal and subconjunctival hemorrhage.

8. Lisman and Intagliata (2022) – Hemostatic and Thrombotic Complications of Liver Disease

The authors examined abnormalities of primary and secondary hemostasis in cirrhosis. They reported that approximately three-fourths of cirrhotic patients exhibit thrombocytopenia. Defective platelet production, reduced thrombopoietin levels, and altered coagulation factor synthesis contribute to an unstable hemostatic balance that can result in spontaneous bleeding episodes.

Relevance to Present Study: Ocular hemorrhage may represent one of the visible manifestations of systemic hemostatic instability in chronic liver disease.

9. Gupta H. et al. (2021) – Spontaneous Subconjunctival and Retinal Hemorrhage in Acute-on-Chronic Liver Failure: A Case Report

Gupta and colleagues described a patient with acute-on-chronic liver failure who developed simultaneous spontaneous subconjunctival and retinal hemorrhages. The patient had severe thrombocytopenia and markedly elevated INR. The authors suggested that profound coagulation abnormalities were responsible for the ocular bleeding manifestations.

Relevance to Present Study: This report directly supports a possible association between liver disease severity, thrombocytopenia, elevated INR, and ocular hemorrhage.

10. Syed Z.A. et al. (MSD Manual Review, 2025) – Subconjunctival Hemorrhage

This clinical review highlighted thrombocytopenia and platelet dysfunction among important systemic causes of spontaneous subconjunctival hemorrhage. Although most SCH cases are benign and self-limiting, recurrent or spontaneous episodes warrant evaluation for underlying hematological disorders. The review stressed the importance of investigating coagulation abnormalities in patients presenting with unexplained SCH.

Study Design This study was conducted in Datta meghe medical college wanadongri nagpur as a prospective observational study to evaluate the occurrence of spontaneous subconjunctival hemorrhage and retinal hemorrhage in patients with chronic liver disease and to assess their association with platelet count, International Normalized Ratio (INR), and disease severity. Study Setting The study was carried out in the Department of Ophthalmology in collaboration with the Department of General Medicine/Gastroenterology at a tertiary care teaching hospital. Study Duration The study was conducted over a period of 18 months from June 2024 to Nov 2025 after the date of approval by the Institutional Ethics Committee. Study Population The study population was comprise of patients diagnosed with chronic liver disease attending the outpatient and inpatient departments of the participating departments during the study period. Sample Size A total of 80 patients with chronic liver disease fulfilling the inclusion and exclusion criteria will be enrolled in the study. Sampling Technique Convenience sampling will be used. Consecutive eligible patients presenting during the study period will be recruited until the required sample size is achieved. Inclusion Criteria Patients fulfilling all of the following criteria will be included in the study: 1. Patients aged more than 18 years. 2. Diagnosed cases of chronic liver disease based on clinical, biochemical, radiological, or histopathological evidence. 3. Patients willing to participate in the study. 4. Patients providing written informed consent. Exclusion Criteria Patients with any of the following conditions will be excluded: 1. History of ocular trauma. 2. Previous ocular surgery. 3. Patients receiving anticoagulant therapy. 4. Presence of retinal diseases unrelated to chronic liver disease, such as diabetic retinopathy, hypertensive retinopathy, or retinal vein occlusion. 5. Known hematological disorders causing thrombocytopenia independent of chronic liver disease. 6. Patients unwilling to participate in the study. Study Procedure After obtaining approval from the Institutional Ethics Committee, eligible patients were recruited from the outpatient and inpatient services. Written informed consent was obtained from all participants before enrollment. A detailed clinical history, systemic examination, ophthalmological evaluation, and laboratory investigations were performed for all study participants. Clinical Evaluation A detailed history was obtained regarding: • Age and sex • Etiology of chronic liver disease • Duration of liver disease • History of alcohol consumption • Previous episodes of gastrointestinal bleeding • Presence of ascites • Hepatic encephalopathy • Current medications • Associated systemic illnesses A complete general and systemic examination were carried out with special emphasis on signs of chronic liver disease such as: • Icterus • Pallor • Pedal edema • Ascites • Spider angioma • Palmar erythema • Hepatosplenomegaly Ophthalmological Evaluation All patients underwent a comprehensive ophthalmic examination by an ophthalmologist. Visual Acuity Assessment Best-corrected visual acuity were assessed using a Logmar visual acuity chart and recorded separately for each eye. Anterior Segment Examination Anterior segment examination were performed using a slit-lamp bio microscope to evaluate: • Eyelids • Conjunctiva • Sclera • Cornea • Anterior chamber • Iris • Lens Particular attention was paid to the presence of spontaneous subconjunctival hemorrhage. Fundus Examination Pupillary dilatation were performed using standard mydriatic agents unless contraindicated. Posterior segment evaluation was carried out using: • Indirect ophthalmoscopy • Slit-lamp biomicroscopy with +90D lens The following findings were documented: • Presence or absence of retinal hemorrhage • Type of retinal hemorrhage (flame-shaped, dot-blot, preretinal, or subhyaloid) • Number and distribution of hemorrhages • Macular involvement • Other associated retinal findings Fundus photography were performed whenever feasible for documentation. Laboratory Investigations The following investigations were recorded for all patients: Hematological Investigations • Complete Blood Count (CBC) • Hemoglobin concentration • Total Leukocyte Count • Platelet Count Coagulation Profile • Prothrombin Time (PT) • International Normalized Ratio (INR) Liver Function Tests • Total Bilirubin • Direct Bilirubin • Serum Albumin • Serum Globulin • Aspartate Aminotransferase (AST) • Alanine Aminotransferase (ALT) • Alkaline Phosphatase (ALP) Radiological Evaluation Ultrasonography of the abdomen findings suggestive of chronic liver disease and portal hypertension will be recorded from patient records. Assessment of Disease Severity The severity of chronic liver disease were assessed using the Child–Pugh scoring system. The following parameters were considered: 1. Serum bilirubin 2. Serum albumin 3. INR/ Prothrombin time 4. Presence of ascites 5. Hepatic encephalopathy Based on the total score, patients classified as: Child–Pugh Class A Score: 5–6 points Child–Pugh Class B Score: 7–9 points Child–Pugh Class C Score: 10–15 points The prevalence of ocular hemorrhages were compared among the three groups Data Collection Data obtained from history, clinical examination, ophthalmological assessment, and laboratory investigations were recorded in a predesigned case record form. All patient information were kept confidential and used solely for research purposes. Statistical Analysis The collected data were entered into Microsoft Excel and analyzed using Statistical Package for Social Sciences (SPSS) software version 26.0 or higher. Descriptive Statistics • Mean ± Standard Deviation (SD) for continuous variables. • Frequencies and percentages for categorical variables. Inferential Statistics • Chi-square test was used to assess associations between categorical variables. • Pearson correlation coefficient was used to determine correlations between platelet count, INR, and ocular hemorrhages. • Student's t-test or ANOVA were applied where appropriate for comparison of continuous variables. A p-value of less than 0.05 was considered statistically significant.

A total of 80 patients diagnosed with chronic liver disease were included in this prospective observational study. All patients underwent detailed ophthalmological examination and relevant laboratory investigations. The findings are presented below.

1. Demographic Profile of Study Population

Table 1: Age Distribution of Patients

The study included 80 patients with chronic liver disease. The majority of patients belonged to the 46–60 years age group (35%), followed by 31–45 years (27.5%), >60 years (25%), and 18–30 years (12.5%).

This distribution indicates that chronic liver disease and its systemic complications, including ocular hemorrhages, are more prevalent in middle-aged and elderly individuals. This can be attributed to the cumulative effect of long-standing etiological factors such as alcohol consumption, viral hepatitis, and metabolic liver disease. Younger patients formed a smaller proportion, suggesting lower disease burden or earlier stage disease in that group.

 Bar Diagram-1 Age Distribution of Patients

Table 2: Gender Distribution

The study showed a male predominance (70%) compared to females (30%).

This male preponderance may be explained by higher prevalence of risk factors such as chronic alcohol consumption, occupational exposure, and higher incidence of viral hepatitis in males in the study population. Additionally, health-seeking behavior differences may also contribute to this distribution.

The finding is consistent with most studies on chronic liver disease, where males are more commonly affected. This also indirectly suggests that ocular hemorrhages observed in the study may be influenced by underlying lifestyle-related liver damage.

Pie Chart 1: Gender Distribution

Table 3: Causes of CLD

Alcoholic liver disease was the most common cause (47.5%), followed by viral hepatitis (27.5%), non-alcoholic fatty liver disease (15%), and other causes (10%).

This pattern reflects the epidemiological trend seen in India and other developing countries, where alcohol-related liver disease remains the leading cause of CLD. Viral hepatitis continues to be a significant contributor, while NAFLD is emerging due to lifestyle changes.

The etiological profile is important because alcohol-related and advanced viral hepatitis cases tend to have more severe coagulopathy and thrombocytopenia, thereby increasing the risk of ocular hemorrhages.

Table 4: Overall Incidence

Among 80 patients:

Subconjunctival hemorrhage (SCH): 22.5%

Retinal hemorrhage: 15%

No hemorrhage: 62.5%

SCH was more frequent than retinal hemorrhage. This is expected because conjunctival vessels are superficial, thin-walled, and more susceptible to rupture even with minor increases in venous pressure or mild coagulation abnormalities.

Retinal hemorrhages were less frequent but clinically more significant, as they indicate deeper microvascular damage and more severe systemic disease.

This table highlights that ocular hemorrhages are not rare in CLD and may serve as early clinical indicators of systemic bleeding tendency.

Table 5: Sub Conjunctival Hemorrhage Laterality

Pie Chart 2: Distribution of Ocular Findings

Most SCH cases were unilateral (77.8%), while bilateral involvement was less common (22.2%).Unilateral SCH suggests localized vessel rupture rather than systemic ocular pathology, although underlying systemic coagulopathy remains the predisposing factor. Bilateral SCH, though less frequent, may indicate more severe systemic derangement or repeated episodes of bleeding tendency.This pattern supports the concept that SCH in CLD is usually spontaneous and focal, rather than diffuse ocular involvement.

Table 6: Type of Retinal Hemorrhage

The most common type observed was:

• Dot-blot hemorrhage (50%)
• Flame-shaped hemorrhage (25%)
• Preretinal hemorrhage (16.7%)
• Subhyaloid hemorrhage (8.3%)

Dot-blot hemorrhages indicate deep retinal capillary involvement, commonly seen in systemic vascular and hematological disorders. Flame-shaped hemorrhages suggest involvement of the nerve fiber layer, while preretinal and subhyaloid hemorrhages indicate more severe vascular rupture closer to the vitreoretinal interface.

This distribution suggests that retinal hemorrhages in CLD are mainly due to micro vascular fragility and hematological abnormalities rather than localized ocular disease.

Graph 2: Bar Diagram – Types of Retinal Hemorrhage

Table 7: Platelet Count vs. Ocular Hemorrhages

A clear inverse relationship was observed:

• Platelets >150,000/µL → minimal SCH (5%) and retinal hemorrhage (2%)
• Platelets 50,000–150,000/µL → moderate increase
• Platelets <50,000/µL → highest incidence (SCH 60%, retinal 45%)

This strongly suggests that thrombocytopenia is a major risk factor for ocular hemorrhages in chronic liver disease.

Mechanistically, reduced platelet count leads to impaired primary hemostasis, increased capillary fragility, and inability to seal minor vascular injuries, resulting in spontaneous bleeding.

This table provides one of the most important findings of the study, confirming a strong inverse correlation between platelet count and ocular hemorrhage severity.

Graph 3: Line Graph – Platelet Count vs. Hemorrhage Risk

Table 8: INR Distribution

The study showed a progressive increase in ocular hemorrhages with rising INR:

• INR <1.5 → minimal risk
• INR 1.5–2.5 → moderate risk
• INR >2.5 → high risk (SCH 55%, retinal 40%)

This indicates a direct correlation between coagulopathy severity and ocular bleeding.

INR reflects the impairment of liver synthetic function and deficiency of clotting factors. Higher INR indicates a bleeding-prone state, making spontaneous subconjunctival and retinal hemorrhages more likely.

This reinforces INR as an important systemic marker for predicting ocular bleeding risk.

Table 9: Severity of CLD and Ocular Hemorrhages

Graph 4: Bar Diagram – INR vs. Hemorrhage Incidence

A clear trend was observed:

• Class A → minimal hemorrhages (SCH 5%, retinal 2%)
• Class B → moderate increase
• Class C → highest incidence (SCH 50%, retinal 35%)

This demonstrates that ocular hemorrhages increase with worsening liver disease severity. Child–Pugh class reflects overall hepatic functional reserve, including bilirubin, albumin, INR, ascites, and encephalopathy. As liver function deteriorates, both thrombocytopenia and coagulopathy worsen, leading to higher bleeding risk.Thus, this table strongly suggests that ocular hemorrhages may act as clinical indicators of advanced liver disease.

The present prospective observational study was conducted to evaluate the incidence and pattern of ocular hemorrhages among patients with chronic liver disease (CLD) and to assess their relationship with hematological and biochemical parameters indicative of hepatic dysfunction. Chronic liver disease is a multisystem disorder associated with several hematological abnormalities, including thrombocytopenia, coagulation defects, platelet dysfunction, and vascular fragility, all of which predispose patients to spontaneous bleeding manifestations. Ocular hemorrhages represent one such manifestation and may serve as clinically detectable markers of underlying systemic coagulopathy.

A total of 80 patients with clinically and radiologically confirmed chronic liver disease were evaluated through detailed ophthalmological examination and laboratory investigations. The findings provide important insights into the prevalence, types, and determinants of ocular hemorrhages in CLD.

Demographic Characteristics

In the present study, the majority of patients belonged to the 46–60 years age group (35%), followed by 31–45 years (27.5%), individuals older than 60 years (25%), and those aged 18–30 years (12.5%). This age distribution suggests that chronic liver disease predominantly affects middle-aged and elderly populations. The finding is consistent with the natural history of CLD, wherein prolonged exposure to etiological factors such as alcohol abuse, chronic viral hepatitis, and metabolic syndrome results in progressive hepatic injury over several years before clinically significant disease becomes evident.

The relatively lower proportion of younger patients may reflect the longer duration required for chronic liver injury to progress to advanced disease stages. Similar observations have been reported in studies evaluating cirrhosis and portal hypertension, where peak incidence occurs in the fifth and sixth decades of life. Since advanced liver disease is associated with worsening coagulopathy and thrombocytopenia, the predominance of older age groups in the present study may partly explain the observed frequency of ocular hemorrhages.

Gender distribution demonstrated a marked male predominance, with males constituting 70% of the study population and females accounting for 30%. This finding is consistent with most epidemiological studies on chronic liver disease. Higher prevalence of alcohol consumption among males remains a major contributing factor. In addition, occupational exposures, increased incidence of viral hepatitis, and differences in health-seeking behavior may further account for male predominance.

The higher proportion of male patients also reflects the etiological pattern observed in the present study, where alcoholic liver disease emerged as the leading cause of chronic liver disease. Consequently, the greater occurrence of ocular hemorrhages among males may indirectly be related to more advance liver dysfunction and coagulopathy resulting from alcohol-related hepatic damage.

Etiological Profile of Chronic Liver Disease

Alcoholic liver disease was identified as the most common etiology, accounting for 47.5% of cases. Viral hepatitis B and C together contributed 27.5%, while non-alcoholic fatty liver disease (NAFLD) accounted for 15% and other causes constituted 10%.

These findings are in agreement with several Indian studies that have reported alcohol-related liver disease as the predominant cause of cirrhosis. Although viral hepatitis remains a major public health concern, increasing awareness, vaccination programs, and antiviral therapies have led to gradual reductions in hepatitis-related cirrhosis in some regions. Simultaneously, NAFLD is emerging as an important cause of chronic liver disease due to rising prevalence of obesity, diabetes mellitus, and metabolic syndrome.

The etiological profile has important implications for bleeding manifestations. Alcoholic liver disease is frequently associated with severe portal hypertension, hypersplenism, thrombocytopenia, nutritional deficiencies, and impaired synthesis of coagulation factors. Similarly, advanced viral hepatitis may result in significant hepatic dysfunction and coagulation abnormalities. Therefore, patients with alcoholic and viral etiologies are expected to exhibit a higher risk of ocular hemorrhages compared with those having earlier-stage metabolic liver disease.

Incidence of Ocular Hemorrhages

One of the principal objectives of the study was to determine the incidence of ocular hemorrhages in chronic liver disease. Among the 80 patients evaluated, subconjunctival hemorrhage (SCH) was observed in 22.5% of patients, retinal hemorrhage in 15%, while 62.5% showed no evidence of ocular hemorrhage.

The overall prevalence of ocular hemorrhagic manifestations observed in this study is clinically significant. More than one-third of patients demonstrated some form of ocular bleeding, emphasizing that ocular involvement is not uncommon in chronic liver disease.

Subconjunctival hemorrhage emerged as the most frequent ocular finding. This observation may be explained by the anatomical characteristics of conjunctival vessels, which are superficial, delicate, and prone to rupture even with minor fluctuations in venous pressure or mild coagulation abnormalities. In patients with liver disease, thrombocytopenia and clotting factor deficiencies further increase susceptibility to spontaneous rupture of these vessels.

Retinal hemorrhages were less common but carry greater clinical importance because they reflect deeper microvascular involvement. Retinal hemorrhage often indicates severe systemic hematological derangement and may potentially affect visual function. The presence of retinal hemorrhage therefore suggests advanced coagulopathy and warrants careful systemic evaluation.

The findings highlight the importance of routine ophthalmological examination in patients with chronic liver disease, particularly those with evidence of advanced hepatic dysfunction.

Pattern of Subconjunctival Hemorrhage

Among the 18 patients with subconjunctival hemorrhage, unilateral involvement was observed in 77.8%, whereas bilateral hemorrhage occurred in only 22.2%.

The predominance of unilateral SCH suggests that most episodes result from focal rupture of conjunctival vessels rather than generalized ocular involvement. Although systemic coagulopathy provides the underlying predisposition, local vascular rupture remains the immediate mechanism responsible for hemorrhage.

Bilateral subconjunctival hemorrhage was comparatively uncommon but may indicate more severe systemic bleeding tendency. In such cases, profound thrombocytopenia or marked coagulation abnormalities may lead to simultaneous involvement of both eyes.

These findings support previous observations that subconjunctival hemorrhage in systemic disorders is usually spontaneous, self-limiting, and unilateral, although bilateral cases may occur in severe coagulopathy states.

Types of Retinal Hemorrhage

Retinal hemorrhage was identified in 12 patients. Dot-blot hemorrhages were the most common type, accounting for 50% of cases, followed by flame-shaped hemorrhages (25%), preretinal hemorrhages (16.7%), and subhyaloid hemorrhages (8.3%).

The predominance of dot-blot hemorrhages suggests that retinal bleeding in chronic liver disease primarily originates from the deeper retinal capillary plexus. Such hemorrhages are commonly associated with systemic vascular and hematological disorders characterized by capillary fragility and impaired hemostasis.

Flame-shaped hemorrhages arise within the retinal nerve fiber layer and indicate involvement of superficial retinal vasculature. Their presence reflects diffuse vascular compromise secondary to hematological abnormalities.

Preretinal and subhyaloid hemorrhages represent more severe forms of retinal bleeding and are generally associated with substantial vascular disruption. Although relatively uncommon in the present study, their occurrence underscores the potential severity of ocular complications in advanced liver disease.

Overall, the pattern of retinal hemorrhages observed supports the concept that ocular manifestations in CLD are primarily consequences of systemic coagulopathy and micro vascular fragility rather than primary retinal pathology.

Relationship between Platelet Count and Ocular Hemorrhages

One of the most significant findings of the present study was the strong inverse association between platelet count and ocular hemorrhages.

Patients with platelet counts above 150,000/µL demonstrated minimal incidence of subconjunctival hemorrhage (5%) and retinal hemorrhage (2%). In contrast, patients with platelet counts below 50,000/µL showed markedly increased incidences of SCH (60%) and retinal hemorrhage (45%).

Thrombocytopenia is a well-recognized complication of chronic liver disease and results from multiple mechanisms, including hypersplenism secondary to portal hypertension, reduced thrombopoietin synthesis by the diseased liver, bone marrow suppression, and immune-mediated platelet destruction.

Platelets play a critical role in primary hemostasis by forming the initial hemostatic plug at sites of vascular injury. Severe thrombocytopenia compromises this process, allowing spontaneous bleeding from fragile capillaries and small vessels. The ocular circulation, particularly conjunctival and retinal capillaries, is especially vulnerable to such bleeding.

The findings of the present study clearly demonstrate that decreasing platelet count is associated with progressively increasing risk of ocular hemorrhage. This observation supports existing evidence identifying thrombocytopenia as one of the most important predictors of spontaneous bleeding in patients with liver disease.

Relationship between INR and Ocular Hemorrhages

The study also demonstrated a strong positive correlation between elevated International Normalized Ratio (INR) and ocular hemorrhages.

Patients with INR below 1.5 showed minimal incidence of ocular hemorrhage, whereas those with INR greater than 2.5 exhibited substantially higher rates of subconjunctival hemorrhage (55%) and retinal hemorrhage (40%).

INR serves as an indirect measure of hepatic synthetic function and reflects deficiencies in clotting factors produced by the liver. Progressive hepatic dysfunction leads to reduced synthesis of coagulation factors II, VII, IX, and X, resulting in prolongation of prothrombin time and elevated INR.

The increasing incidence of ocular hemorrhages with rising INR observed in this study highlights the role of coagulation factor deficiency in the pathogenesis of bleeding manifestations. Patients with elevated INR possess diminished capacity to stabilize vascular injury, predisposing them to spontaneous hemorrhage even in the absence of trauma.

These findings suggest that INR may serve as a useful predictor for identifying CLD patients at increased risk of ocular bleeding complications.

Severity of Liver Disease and Ocular Hemorrhages

An important objective of the study was to evaluate the relationship between severity of liver disease and occurrence of ocular hemorrhages. Child–Pugh Class A patients demonstrated the lowest incidence of hemorrhage, whereas Class C patients exhibited the highest rates of both subconjunctival and retinal hemorrhages.

Subconjunctival hemorrhage increased from 5% in Child–Pugh Class A to 20% in Class B and 50% in Class C. Similarly, retinal hemorrhage increased from 2% in Class A to 15% in Class B and 35% in Class C.

The Child–Pugh classification incorporates bilirubin, albumin, INR, ascites, and hepatic encephalopathy to assess overall hepatic functional reserve. Progression from Class A to Class C reflects worsening liver dysfunction and increasing systemic complications.

Advanced liver disease is associated with severe thrombocytopenia, profound coagulopathy, endothelial dysfunction, portal hypertension, and nutritional deficiencies. These factors collectively contribute to increased bleeding tendency and explain the higher frequency of ocular hemorrhages observed among Child–Pugh Class C patients.

The present findings therefore indicate that ocular hemorrhages may serve as readily detectable clinical markers of advanced liver disease. Their presence should prompt clinicians to evaluate the severity of hepatic dysfunction and underlying hematological abnormalities.

Clinical Significance

The clinical significance of the present study lies in demonstrating that ocular hemorrhages are relatively common manifestations of chronic liver disease and correlate strongly with established indicators of hepatic decompensation. Subconjunctival hemorrhage may represent an early warning sign of systemic bleeding tendency, while retinal hemorrhage may indicate more severe hematological compromise.

Routine ophthalmological examination in patients with advanced CLD could facilitate early detection of bleeding manifestations and provide additional information regarding disease severity. Identification of ocular hemorrhages should prompt assessment of platelet count, coagulation profile, and overall hepatic function.

Furthermore, ocular findings may serve as non-invasive indicators of worsening liver disease and help identify patients requiring closer monitoring and aggressive management.

The present prospective observational study was undertaken to evaluate the incidence and pattern of ocular hemorrhages in patients with chronic liver disease (CLD) and to determine their relationship with hematological and biochemical parameters indicative of hepatic dysfunction. Chronic liver disease is a multisystem disorder associated with significant alterations in hemostasis, including thrombocytopenia, coagulation abnormalities, and vascular fragility, all of which contribute to an increased risk of spontaneous bleeding manifestations. The eye, being richly vascularized and easily accessible for clinical examination, provides a unique opportunity to detect such bleeding tendencies. In this study, 80 patients with chronic liver disease underwent detailed ophthalmological evaluation along with relevant laboratory investigations. The findings demonstrated that ocular hemorrhages are relatively common in patients with CLD, occurring in a significant proportion of cases. Subconjunctival hemorrhage was the most frequently observed ocular manifestation, followed by retinal hemorrhage. Although a majority of patients did not exhibit ocular bleeding, more than one-third of the study population showed evidence of hemorrhagic ocular involvement, highlighting the clinical relevance of routine ophthalmic assessment in these patients. The demographic profile revealed that chronic liver disease predominantly affected middle-aged and elderly individuals, with the highest proportion of patients belonging to the 46–60 years age group. A marked male predominance was observed, reflecting the higher prevalence of risk factors such as chronic alcohol consumption and viral hepatitis among men. Alcoholic liver disease emerged as the most common etiology of CLD, followed by viral hepatitis and non-alcoholic fatty liver disease. This etiological distribution is consistent with current epidemiological trends and underscores the continuing burden of alcohol-related liver injury. An important observation of the study was the predominance of unilateral subconjunctival hemorrhage, suggesting that focal vascular rupture is the most common mechanism of bleeding despite the presence of systemic coagulation abnormalities. Among retinal hemorrhages, dot-blot hemorrhages were the most frequent type, indicating involvement of the deep retinal capillary plexus and reflecting underlying micro vascular fragility associated with hematological disturbances. The study established a strong association between thrombocytopenia and ocular hemorrhages. Patients with platelet counts below 50,000/µL exhibited the highest incidence of both subconjunctival and retinal hemorrhages, whereas those with normal platelet counts showed minimal ocular involvement. This finding confirms that thrombocytopenia is a major determinant of spontaneous ocular bleeding in chronic liver disease and emphasizes the critical role of platelets in maintaining vascular integrity and hemostasis. Similarly, a significant positive correlation was observed between elevated International Normalized Ratio (INR) and the occurrence of ocular hemorrhages. Patients with severe coagulopathy, reflected by INR values greater than 2.5, demonstrated substantially higher rates of ocular bleeding. This relationship highlights the contribution of impaired hepatic synthesis of coagulation factors to the pathogenesis of hemorrhagic manifestations in CLD and reinforces the value of INR as an important predictor of bleeding risk. Another key finding of the study was the progressive increase in ocular hemorrhages with worsening severity of liver disease as assessed by the Child–Pugh classification. Patients belonging to Child–Pugh Class C had the highest incidence of both subconjunctival and retinal hemorrhages, whereas those in Class A showed minimal ocular involvement. This observation indicates that ocular hemorrhages are closely linked to advanced hepatic dysfunction and may serve as visible clinical indicators of disease progression and hepatic decompensation. Based on the findings of the present study, it can be concluded that ocular hemorrhages constitute an important yet often under recognized manifestation of chronic liver disease. Their occurrence is strongly associated with thrombocytopenia, elevated INR, and advanced Child–Pugh class, all of which are markers of severe hepatic impairment. Subconjunctival and retinal hemorrhages may therefore serve as useful clinical indicators of underlying systemic coagulopathy and worsening liver function. Routine ophthalmological examination should be considered as part of the comprehensive evaluation of patients with chronic liver disease, particularly in those with advanced disease, severe thrombocytopenia, or deranged coagulation profiles. Early identification of ocular hemorrhages may facilitate timely recognition of systemic bleeding risk and aid in risk stratification, monitoring, and management of these patients. In conclusion, the present study demonstrates that ocular hemorrhages are not uncommon in chronic liver disease and are significantly associated with the severity of hepatic dysfunction. The findings support the role of ophthalmic examination as a valuable adjunct in the clinical assessment of CLD and highlight the need for multidisciplinary collaboration between hepatologists and ophthalmologists for optimal patient care.

1.      Sherlock S, Dooley J. Diseases of the Liver and Biliary System. 13th ed. Oxford: Wiley-Blackwell; 2018.

2.      Friedman SL, Schiano TD. Cirrhosis and its complications. In: Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 11th ed. Philadelphia: Elsevier; 2021. p. 1652-89.

3.      Harrison TR, Jameson JL, Fauci AS, Kasper DL, Hauser SL, Loscalzo J. Harrison's Principles of Internal Medicine. 21st ed. New York: McGraw-Hill Education; 2022.

4.      Bosch J, Abraldes JG, Berzigotti A, García-Pagán JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol. 2009;6(10):573-82.

5.      Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365(2):147-56.

6.      Lisman T, Leebeek FWG, de Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol. 2002;37(2):280-7.

7.      Northup PG, Caldwell SH. Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol. 2013;11(9):1064-74.

8.      Afdhal N, McHutchison J, Brown R, Jacobson I, Manns M, Poordad F, et al. Thrombocytopenia associated with chronic liver disease. J Hepatol. 2008; 48(6):1000-7.

9.      Giannini EG, Borro P, Botta F, Fumagalli A, Malfatti F, Podestà E, et al. Platelet count and portal hypertension in liver cirrhosis. J Hepatol. 2003;38(6):717-23.

10.   Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008; 371(9615):838-51.

11.   European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406-60.

12.   Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification and management. Hepatology. 2017; 65(1):310-35.

13.   Kanski JJ, Bowling B. Clinical Ophthalmology: A Systematic Approach. 9th ed. Edinburgh: Elsevier; 2020.

14.   Yanoff M, Duker JS. Ophthalmology. 6th ed. Philadelphia: Elsevier; 2022.

15.   Ryan SJ. Retina. 6th ed. Philadelphia: Elsevier; 2018.

16.   American Academy of Ophthalmology. Basic and Clinical Science Course: Retina and Vitreous. San Francisco: AAO; 2023.

17.   Duke-Elder S. System of Ophthalmology. Vol. 10. London: Henry Kimpton; 1967.

18.   Foster CS, Vitale AT. Diagnosis and Treatment of Uveitis. 3rd ed. New Delhi: Jaypee Brothers; 2013.

19.   Tso MOM, Jampol LM. Pathophysiology of retinal hemorrhages. Surv Ophthalmol. 1982; 27(5):255-72.

20.   Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med. 2004;351(22):2310-7.

21.   Duke-Elder S, MacFaul PA. Ocular manifestations of systemic diseases. Br J Ophthalmol. 1975; 59(6):321-9.

22.   Qamar AA, Grace ND, Groszmann RJ, Garcia-Tsao G, Bosch J, Burroughs AK, et al. Platelet count as a marker of portal hypertension in cirrhosis. Hepatology. 2009; 49(1):195-202.

23.   Peck-Radosavljevic M. Thrombocytopenia in liver disease. Can J Gastroenterol. 2000;14(Suppl D):60D-66D.

24.   Runyon BA. AASLD Practice Guideline: Management of adult patients with ascites due to cirrhosis. Hepatology. 2013; 57(4):1651-3.

25.   D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of cirrhosis. Hepatology. 2006;44(1):217-31.

26.   Child CG, Turcotte JG. Surgery and portal hypertension. In: Child CG, editor. The Liver and Portal Hypertension. Philadelphia: Saunders; 1964. p. 50-64.

27.   Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973; 60(8):646-9.

28.   Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014; 383(9930):1749-61.

29.   World Health Organization. Global hepatitis report 2017. Geneva: World Health Organization; 2017.

30.  Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019; 70(1):151-71.